Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc.（IKT）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · IKT · 截至 Jun 10, 2026
关键指标
探索 Inhibikase Therapeutics, Inc. 数据
ikt stock data · financials关于 Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. operates as a pharmaceutical firm in the clinical development stage, concentrating its efforts on pioneering treatments for Parkinson's Disease (PD) and a range of associ…
what is inhibikase therapeutics, inc. · ikt stock overview · inhibikase therapeutics, inc. company profile · who is inhibikase therapeutics, inc. ceo · ikt NASDAQ · inhibikase therapeutics, inc. headquarters · inhibikase therapeutics, inc. business segments
关于股票概览与关键数据
Inhibikase Therapeutics, Inc.（IKT）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 23, 2020 在 NASDAQ 上市。截至最近交易日，IKT 股价为 $1.62，市值约为 $213.9M。过去12个月累计回报 —，年初至今回报 —。
常见问题
截至最近一个交易日，Inhibikase Therapeutics, Inc.（IKT）股价为 $1.62，在 NASDAQ 上市，52周区间为 $1.33 – $2.26。